PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmcpsycBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Psychiatry
 
BMC Psychiatry. 2011; 11: 12.
Published online 2011 January 14. doi:  10.1186/1471-244X-11-12
PMCID: PMC3036590
Disrupting the rhythm of depression using Mobile Cognitive Therapy for recurrent depression: randomized controlled trial design and protocol
Claudi LH Bockting,corresponding author1 Gemma D Kok,1 Lillian van der Kamp,2 Filip Smit,2,3 Evelien van Valen,4 Robert Schoevers,5 Harm van Marwijk,6 Pim Cuijpers,7 Heleen Riper,3 Jack Dekker,7,8 and Aaron T Beck9
1Department of Clinical and Experimental Psychology, Groningen University, Groningen, The Netherlands
2Centre of Prevention and Early Intervention, Trimbos Institute (Netherlands Institute of Mental health and Addiction), Utrecht, The Netherlands
3Department of Epidemiology and Biostatistics, VU University medical centre, Amsterdam, The Netherlands
4Netherlands Center for Occupational Diseases, Coronel Institute of Occupational Health, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
5Department of Psychiatry, University Medical Center Groningen, Groningen, The Netherlands
6Department of General Practice and the EMGO Institute for Health and Care Research (EMGO+), VU University medical centre, Amsterdam, The Netherlands
7Department of Clinical Psychology of the Vrije Universiteit, Amsterdam, The Netherlands
8Mental Health Care Center Arkin/PuntP, Amsterdam, The Netherlands
9Department of Psychiatry, University of Pennsylvania, Philadelphia, USA
corresponding authorCorresponding author.
Claudi LH Bockting: C.L.H.Bockting/at/rug.nl; Gemma D Kok: g.d.kok/at/rug.nl; Lillian van der Kamp: lkamp/at/trimbos.nl; Filip Smit: fsmit/at/trimbos.nl; Evelien van Valen: e.vanvalen/at/amc.uva.nl; Robert Schoevers: r.a.schoevers/at/psy.umcg.nl; Harm van Marwijk: hwj.vanmarwijk/at/vumc.nl; Pim Cuijpers: p.cuijpers/at/psy.vu.nl; Heleen Riper: h.riper/at/psy.vu.nl; Jack Dekker: jack.dekker/at/arkin.nl; Aaron T Beck: abeck/at/mail.med.upenn.edu
Received December 10, 2010; Accepted January 14, 2011.
Abstract
Background
Major depressive disorder (MDD) is projected to rank second on a list of 15 major diseases in terms of burden in 2030. The major contribution of MDD to disability and health care costs is largely due to its highly recurrent nature. Accordingly, efforts to reduce the disabling effects of this chronic condition should shift to preventing recurrence, especially in patients at high risk of recurrence. Given its high prevalence and the fact that interventions are necessary during the remitted phase, new approaches are needed to prevent relapse in depression.
Methods/design
The best established effective and available psychological intervention is cognitive therapy. However, it is costly and not available for most patients. Therefore, we will compare the effectiveness and cost-effectiveness of self-management supported by online CT accompanied by SMS based tele-monitoring of depressive symptomatology, i.e. Mobile Cognitive Therapy (M-CT) versus treatment as us usual (TAU). Remitted patients (n = 268) with at least two previous depressive episodes will be recruited and randomized over (1) M-CT in addition to TAU versus (2) TAU alone, with follow-ups at 3, 12, and 24 months. Randomization will be stratified for number of previous episodes and type of treatment as usual. Primary outcome is time until relapse/recurrence over 24 months using DSM-IV-TR criteria as assessed by the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID). For the economic evaluation the balance between costs and health outcomes will be compared across strategies using a societal perspective.
Discussion
Internet-based interventions might be helpful in empowering patients to become their own disease managers in this lifelong recurrent disorder. This is, as far as we are aware of, the first study that examines the (cost) effectiveness of an E-mental health program using SMS monitoring of symptoms with therapist support to prevent relapse in remitted recurrently depressed patients.
Trial registration
Netherlands Trial Register (NTR): NTR2503
Articles from BMC Psychiatry are provided here courtesy of
BioMed Central